Replidyne, Inc. is a biotechnology company based in Louisville, Colorado, specializing in the development of innovative solutions for infectious diseases. The organization focuses on advancing therapeutic and diagnostic technologies aimed at improving patient outcomes. With a commitment to scientific research and collaboration, Replidyne is dedicated to addressing unmet medical needs through its expertise in microbiology and pharmacology, contributing to the broader healthcare landscape.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Oct 13 2026

12 Patents

#27 in Louisville, CO

#535 in Colorado

#25,557 in US

#48,163 in the World

Louisville, CO, United States of America

Replidyne, Inc.

Forward Citations = 25

22 inventors:

Elizabeth Jane Lawlor (4 out of 99 patents)

Richard Lewis Jarvest (3 out of 19 patents)

John Michael Berge (3 out of 7 patents)

4. John Edward Hodgson (3 out of 105 patents)

5. Daniel Robert Gentry (3 out of 24 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Replidyne, Inc.. Retrieved from https://idiyas.com/company/replidyne

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]